Amanda Psyrri

18.4k citations

251 papers · 7.2k indexed · 2 hit papers · h-index 48

Impact in

Otorhinolaryngology top 0.1%
- Head and Neck Cancer Studies
Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways

Papers in

Otorhinolaryngology 68
- Head and Neck Cancer Studies 68
Oncology 155
- Cancer Immunotherapy and Biomarkers 45
- HER2/EGFR in Cancer Research 19
- Cancer Diagnosis and Treatment 18
- Cancer-related Molecular Pathways 16

Co-authors: Panagiota Economopoulou Clarence T. Sasaki David L. Rimm Paul Weinberger Ioannis Kotsantis Ziwei Yu Robert L. Camp Bruce G. Haffty
Journals: Journal of Clinical Oncology (30 papers)Annals of Oncology (29 papers)Clinical Cancer Research (14 papers)Oral Oncology (13 papers)Cancers (8 papers)
Partner nations: Greece United States United Kingdom

In The Last Decade

Amanda Psyrri

239 papers receiving 7.1k citations

Hit Papers

align trajectories log scale

Immunotherapy for pancreatic cancer: A 2020 update 2020 · 308 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Cancer Treatment Reviews
2006 Journal of Clinical Oncology

Peers

Countries citing papers authored by Amanda Psyrri

Since Specialization

Citations

This map shows the geographic impact of Amanda Psyrri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Psyrri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Psyrri more than expected).

Fields of papers citing papers by Amanda Psyrri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Psyrri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Psyrri. The network helps show where Amanda Psyrri may publish in the future.

Co-authors

The 25 scholars most cited alongside Amanda Psyrri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amanda Psyrri Line = papers co-authored together Amanda Psyrri links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers International Journal of Molecular Sciences ·Αreti Strati, Christos Adamopoulos, Ioannis Kotsantis, Amanda Psyrri, Evi Lianidou, Athanasios G. Papavassiliou	2025	13
2	Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma Cancer Immunology Immunotherapy ·Tanguy Y. Seiwert, Sophie Wildsmith, Jérôme Fayette, Kevin J. Harrington, Maura L. Gillison, Myung‐Ju Ahn, Shunji Takahashi, Jared Weiss, Jean‐Pascal Machiels, Shrujal S. Baxi, Valerie L. Baker, Brent Evans, Nassim Morsli, Jill Walker, 권진규, Anne L’Hernault, Amanda Psyrri	2024	6
3	Real-world data on the safety and efficacy of trastuzumab deruxtecan and sacituzumab govitecan in patients with advanced breast cancer: the experience of the Hellenic Cooperative Oncology Group European Journal of Cancer ·Elena Fountzilas, Hamidou Souleymane TAPILY, T. N. Samoilovich, Takumi ARANO, حشمت عزیزی فر, Anna Koumarianou, D. Alley, Kolodiazhnaia Olga Iurevna, Davide Mauri, Sofia Karageorgopoulou, E. Razis, Athina Christopoulou, Yuan Xili, Simon Guillaumet, Flora Zagouri, Maya Ferdiana Rozalia, Shambo Bhattacharjee, Dimitrios Tryfonopoulos, Amanda Psyrri, Αngelos Koutras	2024	0
4	Evasion of apoptosis and treatment resistance in squamous cell carcinoma of the head and neck Cancer Treatment Reviews ·Ben O’Leary, Heath D. Skinner, Jonathan D. Schoenfeld, Lisa Licitra, Christophe Le Tourneau, Christina Esdar, Andreas Schröeder, S. K. Koishybaeva, Amanda Psyrri	2024	7
5	Direct comparison of an ultrasensitive real-time PCR assay with droplet digital PCR for the detection of PIK3CA hotspot mutations in primary tumors, plasma cell-free DNA and paired CTC-derived gDNAs Frontiers in Oncology ·А. Drizhenko, Loukas Kaklamanis, Anirban Karmakar, Helena Linardou, Meredith McLerie, Perttu Immonen, Evangelia Razis, Stylianos Kakolyris, Amanda Psyrri, Christos Papadimitriou, Athina Markou, Evi Lianidou	2024	1
6	Immune checkpoint inhibitors in sarcomas: a systematic review Immuno-Oncology Technology ·Μaria Anastasiou, Anastasios Kyriazoglou, Ioannis Kotsantis, Panagiota Economopoulou, R.V. Alexeenko, N. Chercheffsky, Randa Roen, Mahmoud S. Eljazzar, Myrto Moutafi, Niki Gavrielatou, Amanda Psyrri	2023	9
7	1435P Clinical and molecular study with digital support of advanced non-small cell lung cancer patients: SNF-CLIMEDIN, a prospective randomized Hellenic Cooperative Oncology Group (HeCOG) study: Interim analysis Annals of Oncology ·Helena Linardou, Waldemar Niklinski, Kyriaki Papadopoulou, Nikolaos Korfiatis, Sofia Lampaki, Elena Fountzilas, Amanda Psyrri, Anastasios Vagionas, Athina Christopoulou, Epaminontas Samantas, Ilias Athanasiadis, Giannis Mountzios, Nikolaos Tsoukalas, Joseph Sgouros, Αngelos Koutras, wvcycling, Atik Sustiwi, George Fountzilas, P. Kosmidis	2023	1
8	106P Treatment sequencing in PD-L1–positive recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Exploratory analysis of the phase III KEYNOTE-048 study Immuno-Oncology Technology ·Richard Greil, Barbara Burtness, Simon Laban, Irene Braña, G. Chen, Thorsten Fuereder, Åse Bratland, Lisa Licitra, Tamara Rordorf, Amanda Psyrri, Aron Popovtzer, Brett Hughes, Makoto Tahara, J. Lin, (unknown), Valerie Lang, Kevin J. Harrington	2023	1
9	Oral Toxicities in Cancer Patients, Who Receive Immunotherapy: A Case Series of 24 Patients SHILAP Revista de lepidopterología ·Ourania Nicolatou‐Galitis, Amanda Psyrri, Nikolaos Tsoukalas, Thomas Busset, Helena Linardou, Dimitra Galiti, Eun-Ji Li, 许平, Evangelia Razis, 太宰宙朗, Nikolaos Kentepozidis, П М Бодяко, Amoon Mohammed Ali Albatool, Efthymios Kyrodimos, Danai Daliani, G. P. Tsironis, Giannis Mountzios, Sofia Karageorgopoulou, Xochitl Hernández Chavira, Konstantinos Syrigos	2023	2
10	Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell Carcinoma Cancer Research Communications ·Niki Gavrielatou, 丁圣彦, Thazin Nwe Aung, Saba Shafi, 崇陽朗丹羽, Aileen I. Fernandez, Myrto Moutafi, Barbara Burtness, Panagiota Economopoulou, Μaria Anastasiou, Periklis Foukas, Amanda Psyrri, David L. Rimm	2023	10
11	The addition of the immunomodulator mifamurtide to adjuvant chemotherapy for early osteosarcoma: a retrospective analysis Investigational New Drugs ·Stefania Kokkali, Ioannis Kotsantis, Majid Khan, ML Metasch, Muhammad Hamidi, Layli Jamali, Shambo Bhattacharjee, Amanda Psyrri, Alexandros Ardavanis	2022	4
12	Genetic Variation in the Vascular Endothelial Growth Factor (VEGFA) Gene at rs13207351 Is Associated with Overall Survival of Patients with Head and Neck Cancer Cancers ·Foteinos‐Ioannis Dimitrakopoulos, Georgia-Angeliki Koliou, Vassiliki Kotoula, Kyriaki Papadopoulou, Konstantinos Markou, Konstantinos Vlachtsis, Nikolaos Angouridakis, Marianela Ciudad S., Angelos Nikolaou, Amanda Psyrri, A. Visvikis, P. Kosmidis, George Fountzilas, Αngelos Koutras	2021	4
13	Multiplexed (18-Plex) Measurement of Signaling Targets and Cytotoxic T Cells in Trastuzumab-Treated Patients using Imaging Mass Cytometry Clinical Cancer Research ·Daniel Carvajal‐Hausdorf, Aparna Kajenthira, Kelly Stanton, Franz Villarroel‐Espíndola, Amanda Esch, Ruth R. Montgomery, Amanda Psyrri, Konstantine T. Kalogeras, Vassiliki Kotoula, Zahara Adelia, Kurt A. Schalper, Yuval Kluger, David L. Rimm	2019	40
14	ESR1 Methylation: A Liquid Biopsy–Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment Clinical Cancer Research ·Sofia Mastoraki, Αreti Strati, Eleni Tzanikou, Maria Chimonidou, Eleni Politaki, Alexandra Voutsina, Amanda Psyrri, Vassilis Georgoulias, Evi Lianidou	2017	126
15	p16, HPV, and Cetuximab: What Is the Evidence? The Oncologist ·James A. Bonner, Ricard Mesı́a, J. Giralt, Amanda Psyrri, Ulrich Keilholz, David I. Rosenthal, Frank Beier, Jeltje Schulten, Jan B. Vermorken	2017	17
16	Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma Clinical Cancer Research ·Maria Vassilakopoulou, Margaritis Avgeris, Vamsidhar Velcheti, Vassiliki Kotoula, Theodore Rampias, Kyriakos Chatzopoulos, Christos Perisanidis, Christos K. Kontos, Aris Ι. Giotakis, Andreas Scorilas, David L. Rimm, Clarence T. Sasaki, George Fountzilas, Amanda Psyrri	2015	173
17	Prognostic Biomarkers in Phase II Trial of Cetuximab-Containing Induction and Chemoradiation in Resectable HNSCC: Eastern Cooperative Oncology Group E2303 Clinical Cancer Research ·Amanda Psyrri, Ju-Whei Lee, Eirini Pectasides, Maria Vassilakopoulou, Efstratios K. Kosmidis, Barbara Burtness, David L. Rimm, Harold J. Wanebo, Arlene A. Forastiere	2014	24
18	Activation of Wnt Signaling Pathway by Human Papillomavirus E6 and E7 Oncogenes in HPV16-Positive Oropharyngeal Squamous Carcinoma Cells Molecular Cancer Research ·Theodore Rampias, Eleni Boutati, Eirini Pectasides, Clarence T. Sasaki, Panteleimon Kountourakis, Paul Weinberger, Amanda Psyrri	2010	98
19	Nuclear Localization of Signal Transducer and Activator of Transcription 3 in Head and Neck Squamous Cell Carcinoma Is Associated with a Better Prognosis Clinical Cancer Research ·Eirini Pectasides, Ann-Marie Egloff, Clarence T. Sasaki, Panteleimon Kountourakis, Barbara Burtness, George Fountzilas, Urania Dafni, Thomas Zaramboukas, Θεόδωρος Ράμπιας, David L. Rimm, Jennifer R. Grandis, Amanda Psyrri	2010	58
20	Phosphatidylinositol 3′-Kinase Catalytic Subunit α Gene Amplification Contributes to the Pathogenesis of Mantle Cell Lymphoma Clinical Cancer Research ·Amanda Psyrri, Sotirios G. Papageorgiou, C. Mai, Andreas Scorilas, Dimitra Rontogianni, Christos K. Kontos, Jihyun Ryoo, Dimitrios Pectasides, Nikolaos Harhalakis, Vassiliki Pappa, Aggeliki Kοlialexi, Christina Economopoulou, Pascal Houndonougbo, Eirini Maratou, George Dimitriadis, Panagiota Economopoulou, Theofanis Economopoulos	2009	86

About Amanda Psyrri

Amanda Psyrri is a scholar working on Otorhinolaryngology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 251 papers that have together received 7.2k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (68 papers), Lung Cancer Treatments and Mutations (53 papers), Cancer Immunotherapy and Biomarkers (45 papers), Cancer Genomics and Diagnostics (29 papers), HER2/EGFR in Cancer Research (19 papers), Cancer Diagnosis and Treatment (18 papers), Cancer-related gene regulation (17 papers) and Cancer-related Molecular Pathways (16 papers). The work is most often cited by research in Otorhinolaryngology (2.1k citations), Oncology (3.7k citations), Cancer Research (1.5k citations), Pulmonary and Respiratory Medicine (1.7k citations) and Periodontics (229 citations). Amanda Psyrri has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Panagiota Economopoulou, Clarence T. Sasaki, David L. Rimm, Paul Weinberger, Ioannis Kotsantis, Ziwei Yu, Robert L. Camp, Bruce G. Haffty, Diane Kowalski and Barbara Burtness. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Oral Oncology and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact